 Kristen Nordenholz
Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 17 | 2021 | 212 | 2.440 |
Why?
| | Venous Thromboembolism | 7 | 2022 | 287 | 0.880 |
Why?
| | Emergency Service, Hospital | 15 | 2021 | 1917 | 0.750 |
Why?
| | Fibrin Fibrinogen Degradation Products | 7 | 2016 | 82 | 0.750 |
Why?
| | Emergency Medicine | 3 | 2023 | 216 | 0.440 |
Why?
| | Anticoagulants | 4 | 2021 | 637 | 0.440 |
Why?
| | Tissue Plasminogen Activator | 4 | 2017 | 222 | 0.420 |
Why?
| | Antithrombins | 1 | 2013 | 58 | 0.420 |
Why?
| | Fibrinolytic Agents | 4 | 2017 | 262 | 0.400 |
Why?
| | Emergency Treatment | 1 | 2013 | 113 | 0.400 |
Why?
| | gamma-Glutamyltransferase | 1 | 2012 | 42 | 0.390 |
Why?
| | Venous Thrombosis | 3 | 2016 | 176 | 0.370 |
Why?
| | Hemorrhage | 2 | 2014 | 679 | 0.330 |
Why?
| | Oximetry | 1 | 2009 | 88 | 0.310 |
Why?
| | Patient Care Team | 1 | 2014 | 601 | 0.310 |
Why?
| | Healthcare Disparities | 1 | 2014 | 580 | 0.280 |
Why?
| | Patient Acceptance of Health Care | 1 | 2014 | 763 | 0.280 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2008 | 86 | 0.270 |
Why?
| | Thromboembolism | 1 | 2007 | 112 | 0.260 |
Why?
| | Burnout, Professional | 2 | 2023 | 408 | 0.260 |
Why?
| | Blood Proteins | 1 | 2008 | 245 | 0.260 |
Why?
| | Sensitivity and Specificity | 8 | 2016 | 1844 | 0.250 |
Why?
| | Diagnostic Imaging | 2 | 2008 | 325 | 0.250 |
Why?
| | Prospective Studies | 14 | 2016 | 7145 | 0.220 |
Why?
| | Biomarkers | 3 | 2017 | 3969 | 0.190 |
Why?
| | Middle Aged | 20 | 2022 | 31165 | 0.180 |
Why?
| | Severity of Illness Index | 1 | 2009 | 2739 | 0.180 |
Why?
| | Mass Screening | 2 | 2021 | 1192 | 0.180 |
Why?
| | Muscarinic Antagonists | 1 | 2000 | 27 | 0.160 |
Why?
| | Renal Insufficiency | 1 | 2022 | 149 | 0.160 |
Why?
| | Drug Contamination | 1 | 2000 | 51 | 0.160 |
Why?
| | Heroin Dependence | 1 | 2000 | 31 | 0.160 |
Why?
| | Humans | 33 | 2023 | 129687 | 0.160 |
Why?
| | Male | 24 | 2022 | 63691 | 0.160 |
Why?
| | Poisoning | 1 | 2000 | 111 | 0.150 |
Why?
| | Female | 24 | 2022 | 68751 | 0.150 |
Why?
| | Respiratory Insufficiency | 1 | 2022 | 313 | 0.150 |
Why?
| | Thrombosis | 1 | 2022 | 349 | 0.150 |
Why?
| | Acute Disease | 3 | 2017 | 980 | 0.140 |
Why?
| | Adult | 16 | 2021 | 35607 | 0.140 |
Why?
| | Predictive Value of Tests | 4 | 2015 | 1950 | 0.140 |
Why?
| | Rivaroxaban | 2 | 2021 | 252 | 0.130 |
Why?
| | Dyspnea | 2 | 2015 | 239 | 0.130 |
Why?
| | Ultrasonography | 2 | 2016 | 712 | 0.130 |
Why?
| | Abdominal Injuries | 1 | 1997 | 118 | 0.120 |
Why?
| | Risk Factors | 8 | 2021 | 9787 | 0.120 |
Why?
| | Physicians | 1 | 2023 | 871 | 0.120 |
Why?
| | Efficiency, Organizational | 1 | 2015 | 133 | 0.110 |
Why?
| | Quality of Life | 3 | 2015 | 2694 | 0.110 |
Why?
| | Radiology | 1 | 2016 | 159 | 0.110 |
Why?
| | Fibrinolysis | 1 | 2015 | 137 | 0.110 |
Why?
| | Dabigatran | 1 | 2013 | 21 | 0.110 |
Why?
| | beta-Alanine | 1 | 2013 | 16 | 0.110 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2013 | 29 | 0.110 |
Why?
| | Wounds, Nonpenetrating | 1 | 1997 | 272 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 4 | 2015 | 2510 | 0.100 |
Why?
| | Morpholines | 1 | 2013 | 123 | 0.100 |
Why?
| | Thiophenes | 1 | 2013 | 117 | 0.100 |
Why?
| | Aged | 9 | 2021 | 22101 | 0.100 |
Why?
| | Benzimidazoles | 1 | 2013 | 162 | 0.100 |
Why?
| | Pyridones | 1 | 2013 | 158 | 0.100 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2015 | 231 | 0.100 |
Why?
| | Probability | 2 | 2014 | 304 | 0.090 |
Why?
| | Diagnosis, Differential | 3 | 2015 | 1433 | 0.090 |
Why?
| | Administration, Oral | 1 | 2013 | 787 | 0.090 |
Why?
| | Radiation Injuries | 1 | 2012 | 135 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2015 | 398 | 0.090 |
Why?
| | Retrospective Studies | 5 | 2022 | 14525 | 0.090 |
Why?
| | Pyrazoles | 1 | 2013 | 403 | 0.080 |
Why?
| | Heparin | 1 | 2012 | 254 | 0.080 |
Why?
| | Medical History Taking | 1 | 2010 | 118 | 0.080 |
Why?
| | Physical Examination | 1 | 2010 | 234 | 0.070 |
Why?
| | False Negative Reactions | 1 | 2008 | 53 | 0.070 |
Why?
| | Peroxidase | 1 | 2008 | 175 | 0.070 |
Why?
| | Area Under Curve | 1 | 2008 | 306 | 0.070 |
Why?
| | Quality of Health Care | 1 | 2012 | 609 | 0.070 |
Why?
| | Research Design | 1 | 2013 | 1045 | 0.070 |
Why?
| | Nephelometry and Turbidimetry | 1 | 2007 | 13 | 0.070 |
Why?
| | HIV Infections | 1 | 2021 | 2730 | 0.070 |
Why?
| | Critical Care | 1 | 2012 | 551 | 0.070 |
Why?
| | Inflammation | 1 | 2017 | 2748 | 0.070 |
Why?
| | Electrocardiography | 1 | 2009 | 611 | 0.060 |
Why?
| | Observer Variation | 1 | 2007 | 314 | 0.060 |
Why?
| | C-Reactive Protein | 1 | 2008 | 401 | 0.060 |
Why?
| | Algorithms | 2 | 2008 | 1616 | 0.060 |
Why?
| | Logistic Models | 4 | 2012 | 1988 | 0.060 |
Why?
| | Odds Ratio | 3 | 2012 | 1021 | 0.050 |
Why?
| | Cohort Studies | 1 | 2014 | 5434 | 0.050 |
Why?
| | Risk Assessment | 2 | 2012 | 3260 | 0.050 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2022 | 89 | 0.050 |
Why?
| | Faculty | 1 | 2022 | 138 | 0.040 |
Why?
| | Decision Trees | 1 | 2021 | 90 | 0.040 |
Why?
| | Indiana | 1 | 2020 | 33 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 198 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2022 | 125 | 0.040 |
Why?
| | Mid-Atlantic Region | 1 | 2000 | 5 | 0.040 |
Why?
| | Cough | 1 | 2021 | 116 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2022 | 204 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2000 | 131 | 0.040 |
Why?
| | Heroin | 1 | 2000 | 30 | 0.040 |
Why?
| | Fever | 1 | 2021 | 298 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2020 | 287 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2014 | 1875 | 0.040 |
Why?
| | Treatment Outcome | 4 | 2021 | 10221 | 0.040 |
Why?
| | Adolescent | 4 | 2013 | 20415 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2010 | 317 | 0.040 |
Why?
| | United States | 4 | 2021 | 13906 | 0.040 |
Why?
| | Survival Analysis | 1 | 2021 | 1270 | 0.040 |
Why?
| | Hypertension, Pulmonary | 1 | 2009 | 1894 | 0.040 |
Why?
| | Convalescence | 1 | 2017 | 18 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2022 | 506 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 2012 | 1500 | 0.030 |
Why?
| | Health Personnel | 1 | 2023 | 656 | 0.030 |
Why?
| | Peritoneal Lavage | 1 | 1997 | 7 | 0.030 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 1997 | 27 | 0.030 |
Why?
| | Disease Outbreaks | 1 | 2000 | 349 | 0.030 |
Why?
| | Length of Stay | 1 | 2021 | 1127 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 718 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2021 | 335 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2007 | 7064 | 0.030 |
Why?
| | Registries | 2 | 2021 | 1896 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1269 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1496 | 0.030 |
Why?
| | Angiography | 1 | 2015 | 196 | 0.030 |
Why?
| | Wounds, Gunshot | 1 | 1997 | 213 | 0.030 |
Why?
| | Suicide, Attempted | 1 | 1997 | 356 | 0.030 |
Why?
| | Shock | 1 | 2014 | 92 | 0.030 |
Why?
| | Contrast Media | 1 | 2015 | 393 | 0.030 |
Why?
| | Lower Extremity | 1 | 2016 | 407 | 0.020 |
Why?
| | Unnecessary Procedures | 1 | 2012 | 48 | 0.020 |
Why?
| | APACHE | 1 | 2012 | 65 | 0.020 |
Why?
| | Echocardiography | 1 | 2015 | 635 | 0.020 |
Why?
| | Blood Coagulation Tests | 1 | 2012 | 60 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2012 | 271 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5083 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 421 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1042 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 1997 | 711 | 0.020 |
Why?
| | Factor Xa Inhibitors | 1 | 2012 | 170 | 0.020 |
Why?
| | Radiography | 1 | 2012 | 797 | 0.020 |
Why?
| | Bundle-Branch Block | 1 | 2009 | 30 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 5427 | 0.020 |
Why?
| | Child | 2 | 2007 | 20882 | 0.020 |
Why?
| | Tachycardia | 1 | 2009 | 57 | 0.020 |
Why?
| | Chest Pain | 1 | 2010 | 88 | 0.020 |
Why?
| | Thrombophilia | 1 | 2010 | 81 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2009 | 137 | 0.020 |
Why?
| | Clinical Competence | 1 | 2016 | 1018 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1290 | 0.020 |
Why?
| | Databases as Topic | 1 | 2008 | 59 | 0.020 |
Why?
| | ROC Curve | 1 | 2008 | 503 | 0.020 |
Why?
| | Time Factors | 1 | 2015 | 6545 | 0.010 |
Why?
| | Age Factors | 1 | 2012 | 3153 | 0.010 |
Why?
| | Quality Improvement | 1 | 2012 | 1108 | 0.010 |
Why?
| | Sex Factors | 1 | 2010 | 1973 | 0.010 |
Why?
| | Obesity | 1 | 2015 | 2885 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2012 | 2470 | 0.010 |
Why?
| | Young Adult | 1 | 2013 | 12457 | 0.010 |
Why?
| | Age Distribution | 1 | 1997 | 372 | 0.010 |
Why?
| | Sex Distribution | 1 | 1997 | 359 | 0.010 |
Why?
| | Self-Injurious Behavior | 1 | 1997 | 124 | 0.010 |
Why?
| | Survival Rate | 1 | 1997 | 1872 | 0.010 |
Why?
| | Firearms | 1 | 1997 | 361 | 0.010 |
Why?
| | Incidence | 1 | 1997 | 2644 | 0.010 |
Why?
| | Mental Disorders | 1 | 1997 | 1035 | 0.000 |
Why?
| | Child, Preschool | 1 | 1997 | 10487 | 0.000 |
Why?
|
|
Nordenholz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|